U.S. strategy for rapid scale-up of ARV treatment
This report provides background on international developments concerning anti-retroviral (ARV) drugs, and on U.S. policy on the issue. It also outlines the key elements identified by leading international organizations as essential for successful scale-up of ARV treatment.
RELATED CONTENT
view allPublication
02/21/2010
Can we measure HIV/AIDS-related stigma and discrimination?
HIV-related stigma and discrimination has accompanied the AIDS epidemic from the start. Fear of and actual experience with stigma and discrimination (S&D) reduce an individual’s willingness to practice prevention, seek…
Publication
Clinical science meets social science
ICRW summarizes the findings of a research study that examined how gender issues influenced volunteers’ decisions to participate in AIDS vaccine research in Kenya and their experience of participation. These…
Publication
Community involvement in initiatives to prevent mother-to-child transmission of HIV
Prevention of mother-to-child transmission must be part of the standard package of care for HIV-positive women. ICRW and the Population Council offer recommendations to policymakers and program managers on how…